efficiencies for solution processed solar
cells. An acclaimed teacher, he has created
several research teams at Purdue that have
secured multimillion-dollar grants for wide-ranging projects.
The director of Purdue’s Center for Drug
Discovery, Low has more than 340
publications and 50 active patents to his
name. More than 70 of his laboratory
students have received Ph.D.s from
Purdue, and he is known for guiding his
students and inspiring them to advance
their research. Low also is known for his
pioneering tumor-targeting technologies
that allow delivery of both imaging
and therapeutic drugs selectively into
cancer cells. Applications of these novel
technologies currently in the clinic include
agents for the treatment and fluorescence-guided surgery of lung, ovarian, kidney,
prostate and endometrial cancers.
A Purdue faculty member since 1984, Delp
has achieved worldwide acclaim for his
work related to image and video processing.
He was one of the first researchers to
investigate multimedia security and he
is a sought-after expert who has worked
with the U.S. Department of Defense, U.S.
Department of Homeland Security and
other federal and state agencies. He has
developed 12 courses related to the subject
at Purdue and has received numerous
teaching awards.
Distinguished Professor
Honored by BioCrossroads
BioCrossroads has honored Philip Low,
the Ralph C. Corley Distinguished Professor
of Chemistry, with the 2013 August M.
Watanabe Life Sciences Champion of the
Year Award.
The prestigious honor named in tribute to
BioCrossroads’ late first chairman is given
annually to an individual or organization
that has made or enabled unique
achievements in the development and
promotion of Indiana’s life sciences research,
educational or economic advancement.
Low has received several national and
international awards, including a National
Institutes of Health MERI T Award and
Purdue University’s award for outstanding
research. In addition to his work at Purdue
University, Low also has guided the
discovery and development of seven drugs
that are currently in human clinical trials for
imaging and therapy of various cancers and
has founded two companies (Endocyte Inc.
and On Target Laboratories LLC) focused
on commercialization of these and other
targeted drugs. He also has been involved
in two other Indiana startup companies.
“Phil Low has the remarkable combination
of being a success in the academic halls,
the research lab and the entrepreneur’s
office. His passion for bringing scientific
discoveries to the market to improve health
and well-being has enabled him to start
companies here in Indiana and to develop
breakthroughs in the treatment of cancer,”
said David Johnson, president and CEO,
BioCrossroads.
Two Profs Named Fellows of
Inventors’ Organization
Two Purdue professors have been named
fellows of the National Academy of
Inventors (NAI):
Rakesh Agrawal, the Winthrop E. Stone
Distinguished Professor in the School
of Chemical Engineering, and Michael
Ladisch, Distinguished Professor in the
Department of Agricultural and Biological
Engineering and Weldon School of
Biomedical Engineering and director of
Purdue’s Laboratory of Renewable Resources
Engineering (LORRE).
They are among 143 new members who
were recognized during an NAI induction
ceremony on March 7 at the U.S. Patent
and Trademark Office headquarters in
Alexandria, Va.
Agrawal holds 120 U.S. patents and has
authored 138 technical papers. In 2011 he
received the National Medal of Technology
and Innovation from President Barack
Obama. In 2013 he was elected to the
Philip Low Rakesh Agrawal Edward Delp Michael Ladisch
The director of Purdue’s Center for Drug
Discovery, Low has more than 340
publications and 50 active patents to his
name. More than 70 of his laboratory
students have received Ph.D.s from
Purdue, and he is known for guiding his
students and inspiring them to advance
their research. Low also is known for his
pioneering tumor-targeting technologies
that allow delivery of both imaging
and therapeutic drugs selectively into
cancer cells. Applications of these novel
technologies currently in the clinic include
agents for the treatment and fluorescence-guided surgery of lung, ovarian, kidney,
prostate and endometrial cancers.
A Purdu faculty member since 1984, Delp
has achieved worldwide acclaim for his
work related to image and video processing.
He was one of the first researchers to
investigate multimedia security and he
is a sought-after expert who has worked
with the U.S. Department of Defense, U.S.
Department of Homeland Security and
other federal and state agencies. He has
developed 12 courses related to the subject
at Purdue and has received numerous
teaching awards.
Distinguished Professor
Honored by BioCrossroads
B o o ro h o P Lo
ph r t i d e s r
Y ar
T e o n m tr te t
BioCrossroads’ late first chairman is given
annually to an individual or organization
that has made or enabled unique
achievements in the development and
promotion of Indiana’s life sciences research,
educational or economic advancement.
ec i s o
tnin a , c i o
In i n
e n ver rd o u t di
a dt t o e
st o osi th
i d pm t f
ar li a f
n py va o n
a de copa oy c
rat es c s
c m zt o n o e
s H ha
o i ttcpi
“ i ha e k l a i n
b gs s d c
a a ad t
office. His passion for bringing scientific
discoveries to the market to improve health
and well-being has enabled him to start
companies here in Indiana and to develop
breakthroughs in the treatment of cancer,”
said David Johnson, president and CEO,
BioCrossroads.
Two Profs Named Fellows of
Inventors’ Organization
Two Purdue professors have been named
fellows of the National Academy of
Inventors (NAI):
Rakesh Agrawal, the Winthrop E. Stone
Distinguished Professor in the School
of Chemical Engineering, and Michael
Ladisch, Distinguished Professor in the
Department of Agricultural and Biological
Engineering and Weldon School of
Biomedical Engineering and director of
Purdue’s Laboratory of Renewable Resources
Engineering (LORRE).
They are among 143 new members who
were recognized during an NAI induction
ceremony on March 7 at the U.S. Patent
and Trademark Office headquarters in
Alexandria, Va.
Agrawal holds 120 U.S. patents and has
authored 138 technical papers. In 2011 he
received the National Medal of Technology
and Innovation from President Barack
Philip Low Rakesh Agrawal Edward Delp Michael Ladisch
